Norav Unveils the NR-314P Holter Device: Where Innovation Meets Everyday Comfort

The New Holter NR-314P:

14 Days of Continuous ECG in Just 41g!

Del Ray, Florida USA & Mainz-Kastel, Germany – 30/10/23 – Norav Medical, a global leader in ECG solutions, has launched the innovative NR-314P Holter device, marking a major advancement in long-term cardiac monitoring.

The compact yet robust NR-314P enables up to 14 days of continuous ambulatory ECG recording and boasts wireless connectivity and an easy-to-use interface.

“The NR-314P sets a new benchmark in long-term Holter monitoring with its extended recording, versatile connectivity, and seamless integration into clinical workflows,” said Y.Kannar, CEO.
“We are proud to introduce this breakthrough that underscores our commitment to pushing the boundaries of ECG technology and delivering unprecedented value to healthcare providers worldwide.”

Innovative 3-Lead ECG Technology: The NR-314P is engineered with cutting-edge 3-lead ECG technology, providing healthcare providers with precise and comprehensive cardiac data essential for accurate diagnosis and effective treatment plans. This advanced technology is the cornerstone of Norav’s longstanding commitment to driving ECG innovation and standards-exceeding excellence.

Extended Ambulatory Recording: With the capability of up to 14-day ambulatory recording, the NR-314P stands as a remarkable tool for continuous cardiac monitoring, enabling early detection and management of cardiac anomalies. Its high-resolution ECG processing ensures the delivery of clear and accurate cardiac data, significantly enhancing patient care and outcomes.

Wireless Connectivity and Easy Interface: The NR-314P is equipped with Bluetooth Its compatibility with EHR/HIS information systems like via  HL7 and DICOM underscores Norav’s dedication to seamless integration and improved workflow efficiency.

User-Friendly and Versatile: Designed with healthcare providers in mind, the NR-314P in combination with Norav’s NH-301 Holter analysis software features A-Fib analysis, pacemaker analysis, patient activity and respiration trends. Moreover, the device can function as a standalone unit or be linked to the Norav ECG Management System (NEMS), demonstrating remarkable versatility.

Uninterrupted Daily Activities: The NR-314P Holter device, weighing just 41 grams, is crafted for minimal interference with daily activities while ensuring continuous cardiac monitoring. Its compact, water-resistant design, coupled with wireless connectivity, promotes user adherence to long-term monitoring. Powered by a rechargeable lithium polymer battery, the NR-314P allows for uninterrupted ECG recording during normal activities, enabling patients to wear the device 24/7 without disruption, confidently going about their day with reliable cardiac monitoring.

 Global Availability: The NR-314P is available globally, catering to the diverse needs of healthcare providers across North America, Europe CE (MDR pending) , Latin America, the Middle East, Asia, and Africa. Norav Medical’s regional headquarters in Del Ray, Florida USA, and Mainz-Kastel, Germany, are ready to support global healthcare communities in enhancing cardiac care through the NR-314P Holter device.

About Norav Medical: For over 30 years, Norav Medical has been synonymous with ECG innovation and standards-exceeding excellence, delivering a wide range of ECG solutions and products globally. Norav’s technologies and products are FDA- and CE-certified, marketed via a worldwide dealer network.


Read more about NR-314P Holter ECG :

Contact Us

    Thank you!

    We will contact you asap!

    We are here


    601 N. Congress Ave. Unit 105, Delray Beach FL 33445


    Christof-Ruthof-Weg 10, D55252 Mainz-Kastel
    Fax: (+49) 6134 567983-14


    株式会社グッドケア 〒460-0026 愛知県名古屋市中区伊勢山1-1-1 伊勢山ビル7B